Determination of β-methyldigoxin and its metabolites by high-performance liquid chromatography and fluorescence polarization immunoassay
- 1 January 1989
- journal article
- research article
- Published by Elsevier in Journal of Chromatography B: Biomedical Sciences and Applications
- Vol. 489 (2) , 425-431
- https://doi.org/10.1016/s0378-4347(00)82925-4
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Spironolactone as a Source of Interference in Commercial Digoxin ImmunoassaysTherapeutic Drug Monitoring, 1987
- Use of Area under the Curve to Estimate Absolute Bioavailability of DigoxinJournal of Pharmaceutical Sciences, 1978
- Pharmacokinetics of β-Methyldigoxin in Healthy Humans II: Oral Studies and BioavailabilityJournal of Pharmaceutical Sciences, 1977
- Pharmacokinetics of β-Methyldigoxin in Healthy Humans I: Intravenous StudiesJournal of Pharmaceutical Sciences, 1977
- Absorption of ?-methyl-digoxin determined after a single dose and under steady state conditionsEuropean Journal of Clinical Pharmacology, 1976
- Bioavailability and pharmacokinetics of ?- methyldigoxin after multiple oral and intravenous dosesEuropean Journal of Clinical Pharmacology, 1976
- Disposition of β-methyldigoxin in manEuropean Journal of Clinical Pharmacology, 1975
- ?-Methyl-digoxinNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1974
- Evaluation of Digoxin Bioavailability in Single-Dose StudiesNew England Journal of Medicine, 1973
- The gastrointestinal uptake of methyldigoxin-12?-3H in manEuropean Journal of Clinical Pharmacology, 1972